Peritoneal Dialysis-associated Peritonitis Clinical Trial
Official title:
Improved Diagnosis of Peritoneal Dialysis Peritonitis by Calorimetry
The purpose of this study is to analyze whether calorimetry compared to conventional methods (i.e.blood culture systems)is superior to diagnose peritoneal dialysis related peritonitis.
Background:
Peritonitis is still considered the most important complication of peritoneal dialysis (PD)
associated with high mortality, therapy failure, and healthcare expenses. We have recently
demonstrated that peritonitis continuous to be the most common reason for technical failure
in PD contributing equally to early and late failure; 12 of 279 patients died as a
consequence of PD associated peritonitis. The diagnosis of peritonitis is typically based on
clinical symptoms, which reflects an already advanced state of inflammation and disease.
Since the implementation of the blood culture system for detection of bacterial growth in PD
effluent more than ten years ago, no considerable progress has been made to improve
diagnosis of PD associated peritonitis. In our own PD population 36 out of 219 (16%)
infectious peritonitis episodes were culture-negative. Usually, detection time of
microorganisms requires at least 12 hours and time to pathogen identification more than 48
hours. Rapidly dividing cells such as bacteria produce heat, which can be measured by
calorimetry. As recently shown, by our research group, calorimetry allows rapid and accurate
diagnosis of bacterial growth in cases of meningitis and in contaminated platelets. In pilot
experiments, we could show the potential and the feasibility of calorimetry for early and
accurate detection of microorganisms in PD fluid.
Hypothesis and aims:
We hypothesize that calorimetry of PD effluent can significantly improve the diagnosis of PD
associated peritonitis by early and accurate detection of pathogens. As compared to
traditional culture methods, calorimetry may (i) have a shorter time to positivity and (ii)
a higher sensitivity without loss of specificity. Specific aims are to evaluate if
calorimetry: (i) is more rapid in detection of microorganisms compared to conventional blood
cultures, (ii) is superior, regarding sensitivity and specificity, in detection of PD
associated peritonitis compared to the standard blood culture system and (iii) is a valuable
tool for pathogen identification by specific heat signal "signatures" received by
calorimetry. The Primary endpoint is the time to positivity of bacterial growth by
calorimetry and conventional blood cultures. The secondary endpoints are the accuracy (i.e.
sensitivity and specificity) of detection rates of microorganism in PD fluid and the rate of
consistency of pathogen identification between calorimetry curves and conventional
microbiological method.
Research plan:
After obtaining informed consent, we will prospectively include in this open-labeled
comparative study all patients aged 16 years or older, who are performing PD at the
University Hospital in the time period from January 2009 through December 2011. PD fluid
will be submitted for conventional screening examination (cell count and differential) and
calorimetry (sterile MonovetteR tube) during routine visit. If PD peritonitis is suspected,
PD fluid will be also inoculated in aerobic and anaerobic culture bottles at bedside under
sterile conditions, each bottle with 10 ml of PD fluid. For calorimetry, 1 ml PD fluid will
be cultivated at 37°C in the calorimeter tubes, containing 2 ml of trypticase soy broth
(TSB). Conventional culture bottles and calorimeter tubes are incubated for a total of 6
days, after which culture and/or calorimetry are regarded negative. Medical records will be
prospectively abstracted for demographic characteristics, clinical, radiographic, laboratory
and microbiological data using a standardized case report form. The sample size calculation
was performed separately for primary and secondary endpoints on the following settings:
0.05, power 80%, two-sided test. To reach statistical significant differences for the
primary endpoint, 286 samples are required for the study. For the secondary endpoint with p0
= 80% (sensitivity of conventional blood cultures), p1 = 95% (sensitivity of calorimetry
cultures), 255 samples are required. With an expected drop-out rate of 5%, approximately 300
samples will be needed. With expected 120-180 samples/year study duration of approximately
2.5 to 3 years is needed.
Expected outcome:
We anticipate that calorimetry will significantly improve the diagnosis of PD-associated
peritonitis. First (primary endpoint), we predict an earlier pathogen detection by
calorimetry; second (secondary endpoint), we expect to increase the sensitivity by 15%
without loss of specificity (>90%). Furthermore, we assume that the most important
pathogens, seen in our PD population (i.e. S. aureus, coagulase-negative staphylococci,
streptococci, enterobacteriaceae) may be identified within 12 hours (compared to > 48 hours
by conventional microbiological methods) with an accuracy of 80%. The ultra-sensitive
calorimetry technique may diagnose PD associated peritonitis in an early disease stage with
high accuracy. This would be the basis of a rapid and targeted antibiotic therapy, which may
significantly influence the outcome of these patients.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03264625 -
The Effects of Oral Vitamin D Supplementation on the Prevention of Peritoneal Dialysis-related Peritonitis
|
Phase 2 | |
Suspended |
NCT05300191 -
In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device
|
||
Completed |
NCT03685747 -
Vancomycin Pharmacokinetics in Patients on Peritoneal Dialysis
|
Phase 1 | |
Recruiting |
NCT03046511 -
Peritonitis Prevention After Insertion of Peritoneal Dialysis Catheter.
|
Phase 3 | |
Recruiting |
NCT05285436 -
A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis
|
N/A | |
Recruiting |
NCT05971537 -
Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis
|
Phase 4 | |
Recruiting |
NCT05860270 -
Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
|
Phase 4 | |
Completed |
NCT01293799 -
Prevention of Peritonitis in Peritoneal Dialysis
|
N/A | |
Withdrawn |
NCT03675854 -
Defining the Optimal Duration of Treatment for "Low-Risk" Peritoneal Dialysis-Related Peritonitis
|
Phase 4 | |
Completed |
NCT05450523 -
Neutrophil Gelatinase-Associated Lipocalin (NGAL) Rapid Test (Colloidal Gold) Clinical Trial Protocol
|
||
Completed |
NCT04515498 -
A Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis
|